Indevus Pharmaceuticals, Inc. (NASDAQ:IDEV)
5.60
-0 (-0%)
| Indevus Pharmaceuticals, Inc. (NASDAQ:IDEV) Delayed : |
| Previous Close |
$5.60 |
|
52 Week High |
$6.15 |
 |
| Open |
$5.60 |
|
52 Week Low |
$1.51 |
| Day High |
$5.60 |
|
P/E |
N/A |
| Day Low |
$5.60 |
|
EPS |
$-0.77 |
| Volume |
824,754 |
|
|
|
| More IDEV Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on IDEV
-
Mar 2, 2009 10:03 AM
Endo Pharma (ENDP) Extends Period of Tender Offer for Shares of Indevus (IDEV)
-
Feb 9, 2009 08:32 AM
Indevus Pharma (IDEV) Announces NIH-Sponsored Study on PRO 2000 Shows Promise in HIV Prevention
-
Jan 8, 2009 01:43 PM
JMP Downgrades Indevus Pharma (IDEV) to Market Perform
-
Jan 7, 2009 01:12 PM
UBS Downgrades Indevus Pharmaceuticals (IDEV) to Neutral
-
Jan 6, 2009 12:06 PM
Unusual 11 Mid-Day Movers 1/6: IDEV, TXCO, ARM, ALD Higher; VDSI, CTDC, SMCI, ENDP Lower
View All Reports
StreetInsider Reports on IDEV by Category
-
Apr 2, 2009 05:46 AM
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
-
Jan 7, 2009 04:55 PM
Analyst upgrades, downgrades and initiations: MU, DRIV, HELE, URBN, AKS...
-
Jan 7, 2009 12:05 PM
Analyst upgrades, downgrades and initiations: MU, DRIV, HELE, URBN, AKS...
-
Jun 5, 2008 05:12 AM
Indevus Pharmaceuticals: Nebido Has Lost Its Libido
-
May 13, 2008 07:08 PM
Indevus Pharmaceuticals Inc. F2Q08 (Qtr End 3/31/08) Earnings Call Transcript
View All Blogs
Comments on IDEV
No comments are currently available.
